Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burak Ersak

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of the Turkish German Gynecological Association|September 7, 2023
The oncologic outcomes of endometrial cancer metastasizing to the adrenal gland and kidney: from case to analysisOkan Aytekin, Fatih Kılıç, Burak Ersak, et al.
The Journal of Obstetrics and Gynaecology Research|March 23, 2025
The role of serum inflammatory markers in determining the severity of cervical lesionsUfuk Atlıhan, Onur Yavuz, Burak Ersak, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Evaluation of the Efficacy of Active Hexose Correlated Compound as an Adjuvant in Reducing Recurrence After Condyloma CauterizationUfuk Atlihan, Onur Yavuz, Can Ata, et al.
The Journal of Obstetrics and Gynaecology Research|July 5, 2021
Malignant struma ovarii: From case to analysisSevgi Ayhan, Fatih Kilic, Burak Ersak, et al.
The Journal of Obstetrics and Gynaecology Research|July 23, 2024
Impact of molecular and histopathological findings on FIGO 2009 stage I endometrial cancer: Transition to FIGO 2023 staging systemHande Nur Öncü, Burak Ersak, Gökçen Ege, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|June 6, 2022
Prognostic value of systemic inflammatory response markers in cervical cancerSevgi Ayhan, Serra Akar, İrem Kar, et al.
Journal of Clinical Medicine|March 27, 2025
Isolated Liver Recurrence After Cytoreduction in High-Grade Serous Ovarian Carcinoma: Experience of a Tertiary Center in TurkeyHande Esra Koca Yıldırım, İzzet Özgürlük, Burak Ersak, et al.
The Journal of Obstetrics and Gynaecology Research|October 19, 2023
Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinomaFatih Kilic, Burak Ersak, Caner Cakir, et al.
Journal of Gynecology Obstetrics and Human Reproduction|January 16, 2021
The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish studyCaner Cakir, Fatih Kilic, Cigdem Kilic, et al.
BMC Women'S Health|June 22, 2024
The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancersAysun Alci, Okan Aytekin, Burak Ersak, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of the Turkish German Gynecological Association|September 7, 2023
The oncologic outcomes of endometrial cancer metastasizing to the adrenal gland and kidney: from case to analysisOkan Aytekin, Fatih Kılıç, Burak Ersak, et al.
The Journal of Obstetrics and Gynaecology Research|March 23, 2025
The role of serum inflammatory markers in determining the severity of cervical lesionsUfuk Atlıhan, Onur Yavuz, Burak Ersak, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Evaluation of the Efficacy of Active Hexose Correlated Compound as an Adjuvant in Reducing Recurrence After Condyloma CauterizationUfuk Atlihan, Onur Yavuz, Can Ata, et al.
The Journal of Obstetrics and Gynaecology Research|July 5, 2021
Malignant struma ovarii: From case to analysisSevgi Ayhan, Fatih Kilic, Burak Ersak, et al.
The Journal of Obstetrics and Gynaecology Research|July 23, 2024
Impact of molecular and histopathological findings on FIGO 2009 stage I endometrial cancer: Transition to FIGO 2023 staging systemHande Nur Öncü, Burak Ersak, Gökçen Ege, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|June 6, 2022
Prognostic value of systemic inflammatory response markers in cervical cancerSevgi Ayhan, Serra Akar, İrem Kar, et al.
Journal of Clinical Medicine|March 27, 2025
Isolated Liver Recurrence After Cytoreduction in High-Grade Serous Ovarian Carcinoma: Experience of a Tertiary Center in TurkeyHande Esra Koca Yıldırım, İzzet Özgürlük, Burak Ersak, et al.
The Journal of Obstetrics and Gynaecology Research|October 19, 2023
Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinomaFatih Kilic, Burak Ersak, Caner Cakir, et al.
Journal of Gynecology Obstetrics and Human Reproduction|January 16, 2021
The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish studyCaner Cakir, Fatih Kilic, Cigdem Kilic, et al.
BMC Women'S Health|June 22, 2024
The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancersAysun Alci, Okan Aytekin, Burak Ersak, et al.
Pageof 4